Your session is about to expire
← Back to Search
Reducing Vaccine Hesitancy for COVID-19
N/A
Recruiting
Led By Alexis Koskan, Ph.D
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (t1), t2 (after 4-week intervention), and t3 (2-months post-intervention)
Awards & highlights
No Placebo-Only Group
Summary
This trial proposes a culturally-grounded intervention to reduce vaccine hesitancy in Hispanic/Latino families & increase their children's COVID-19 vaccine uptake.
Who is the study for?
This trial is for Hispanic parents or guardians of children under 18 who haven't had their COVID-19 vaccinations up to date. Participants must self-identify as Hispanic, be willing to communicate via text, and provide a photo of their child's immunization record.
What is being tested?
The study tests if digital storytelling can reduce vaccine hesitancy among Hispanic parents. It involves comparing the effects of receiving culturally-tailored stories about vaccines with just getting basic information.
What are the potential side effects?
Since this trial focuses on behavioral interventions like information sharing and storytelling, there are no direct medical side effects. However, participants may experience changes in attitudes towards vaccines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (t1), t2 (after 4-week intervention), and t3 (2-months post-intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (t1), t2 (after 4-week intervention), and t3 (2-months post-intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Child's COVID-19 vaccine uptake
Intentions to vaccinate child(ren) against COVID-19
Parental COVID-19 vaccine hesitancy
Secondary study objectives
Parents' attitudes about vaccinating their child(ren) against COVID-19
Parents' perceived behavioral control to vaccinate their child(ren) against COVID-19
Parents' perceived norms about vaccinating their child(ren) against COVID-19
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Baseline and Digital Storytelling (DST)Experimental Treatment2 Interventions
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
Group II: Baseline and ControlActive Control2 Interventions
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital Storytelling Intervention
2019
N/A
~580
Find a Location
Who is running the clinical trial?
Arizona State UniversityLead Sponsor
303 Previous Clinical Trials
108,008 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,067 Previous Clinical Trials
2,747,364 Total Patients Enrolled
Alexis Koskan, Ph.DPrincipal InvestigatorArizona State University
Sunny W Kim, Ph.DPrincipal InvestigatorArizona State University
1 Previous Clinical Trials
50 Total Patients Enrolled